Literature DB >> 32819614

Future of Radiation and Immunotherapy.

Silvia C Formenti1, Sandra Demaria2.   

Abstract

Mesh：

Year:  2020        PMID： 32819614     DOI： 10.1016/j.ijrobp.2020.04.034

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  5 in total

1.  A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging.

Authors:  Aki Morikawa; Milan Grkovski; Sujata Patil; Komal L Jhaveri; Kendrick Tang; John L Humm; Andrei Holodny; Kathryn Beal; Heiko Schöder; Andrew D Seidman
Journal:  Breast Cancer Res Treat       Date:  2021-06-10       Impact factor: 4.872

Review 2.  The Abscopal Effect: Could a Phenomenon Described Decades Ago Become Key to Enhancing the Response to Immune Therapies in Breast Cancer?

Authors:  Hans-Christian Kolberg; Oliver Hoffmann; René Baumann
Journal:  Breast Care (Basel)       Date:  2020-10-06       Impact factor: 2.860

3.  A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy.

Authors:  Vikram Adhikarla; Dennis Awuah; Alexander B Brummer; Enrico Caserta; Amrita Krishnan; Flavia Pichiorri; Megan Minnix; John E Shively; Jeffrey Y C Wong; Xiuli Wang; Russell C Rockne
Journal:  Cancers (Basel)       Date:  2021-10-15       Impact factor: 6.575

Review 4.  Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.

Authors:  Sergi Benavente; Almudena Sánchez-García; Silvia Naches; Matilde Esther LLeonart; Juan Lorente
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

5.  Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago.

Authors:  Anis Ahmad; Lakshmi Santanam; Abhishek A Solanki; Laura Padilla; Erina Vlashi; Patrizia Guerrieri; Michael M Dominello; Jay Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2020-11-24       Impact factor: 2.243
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.